Nunzia Pharmaceutical Corporation
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Com… Read more
Market Cap & Net Worth: Nunzia Pharmaceutical Corporation (NUNZ)
Nunzia Pharmaceutical Corporation (PINK:NUNZ) has a market capitalization of $1.30 Million ($1.30 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #42563 globally and #13744 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nunzia Pharmaceutical Corporation's stock price $0.00 by its total outstanding shares 434514578 (434.51 Million).
Nunzia Pharmaceutical Corporation Market Cap History: 2015 to 2025
Nunzia Pharmaceutical Corporation's market capitalization history from 2015 to 2025. Data shows change from $304.16 Million to $1.30 Million (-80.68% CAGR).
Nunzia Pharmaceutical Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nunzia Pharmaceutical Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of NUNZ by Market Capitalization
Companies near Nunzia Pharmaceutical Corporation in the global market cap rankings as of March 19, 2026.
Key companies related to Nunzia Pharmaceutical Corporation by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Nunzia Pharmaceutical Corporation Historical Marketcap From 2015 to 2025
Between 2015 and today, Nunzia Pharmaceutical Corporation's market cap moved from $304.16 Million to $ 1.30 Million, with a yearly change of -80.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.30 Million | 0.00% |
| 2024 | $1.30 Million | 0.00% |
| 2023 | $1.30 Million | -96.25% |
| 2022 | $34.76 Million | -87.69% |
| 2021 | $282.48 Million | -78.33% |
| 2020 | $1.30 Billion | -72.35% |
| 2019 | $4.71 Billion | -99.99% |
| 2018 | $52.11 Trillion | -2.00% |
| 2017 | $53.17 Trillion | +2397.50% |
| 2016 | $2.13 Trillion | +699900.00% |
| 2015 | $304.16 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Nunzia Pharmaceutical Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.30 Million USD |
| MoneyControl | $1.30 Million USD |
| MarketWatch | $1.30 Million USD |
| marketcap.company | $1.30 Million USD |
| Reuters | $1.30 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.